Novartis AG (NVSEF)
Data as of August 11, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does Novartis AG do?
🔬 Novartis AG is a global healthcare company that develops, manufactures, and markets prescription medicines and healthcare products worldwide. From ophthalmology to cardiovascular health, they've got you covered! 🏥 Based in Basel, Switzerland, Novartis is all about improving lives through innovative solutions. 💪.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛈️ Weak | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $151.42 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Novartis AG has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
How the business works
🔬 Novartis AG is a global healthcare company that develops, manufactures, and markets prescription medicines and healthcare products worldwide. From ophthalmology to cardiovascular health, they've got you covered! 🏥 Based in Basel, Switzerland, Novartis is all about improving lives through innovative solutions. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth has been challenging recently. Revenue or earnings are showing weak trends. Sign up free to see the full picture including forward projections.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.